We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$339M
1-Year Est. Return
120.53%
This Fund
S&P 500
This Quarter
Est. Return
+67.38%
1 Year Est. Return
+120.53%
3 Year Est. Return
+331.5%
5 Year Est. Return
+431.82%
10 Year Est. Return
+4,350.35%
AUM
$339M
AUM Growth
+$76.1M
(+29%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-6.88%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
143
New
13
Increased
21
Reduced
79
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantheus
LNTH
|
+$3.54M |
| 2 |
Alignment Healthcare
ALHC
|
+$3.14M |
| 3 |
SGHC Ltd
SGHC
|
+$2.68M |
| 4 |
NUAI
New Era Energy & Digital Inc
NUAI
|
+$2.41M |
| 5 |
Axsome Therapeutics
AXSM
|
+$2.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MaxLinear
MXL
|
+$12.8M |
| 2 |
Applied Optoelectronics
AAOI
|
+$7.92M |
| 3 |
PR
Permian Resources
PR
|
+$3.7M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.9M |
| 5 |
NPKI
NPK International
NPKI
|
+$2.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.02% |
| 2 | Healthcare | 20.7% |
| 3 | Industrials | 18.36% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Financials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
MaxLinear
MXL
$6.8B
| $17.4M | 5.15% |
136,174
-180,650
| -57% | -$12.8M |
|
2
Carpenter Technology
CRS
$22.2B
| $16.9M | 4.99% |
27,425
-1,750
| -6% | -$824K |
|
|
3
Alignment Healthcare
ALHC
$2.6B
| $11.6M | 3.43% |
487,369
+163,350
| +50% | +$3.14M |
|
|
4
Applied Optoelectronics
AAOI
$9.02B
| $11.3M | 3.34% |
76,405
-48,731
| -39% | -$7.92M |
|
5
Sterling Infrastructure
STRL
$15.8B
| $9.12M | 2.69% |
10,863
-863
| -7% | -$606K |
|
6
Copa Holdings
CPA
$5.28B
| $8.95M | 2.64% |
57,508
+3,765
| +7% | +$490K |
|
7
Adaptive Biotechnologies
ADPT
$3.85B
| $8.21M | 2.42% |
382,840
+101,744
| +36% | +$1.56M |
|
8
ATI
ATI
$27.4B
| $8.09M | 2.39% |
41,060
-805
| -2% | -$136K |
|
9
Adtran
ADTN
$612M
| $7.97M | 2.35% |
573,128
-51,896
| -8% | -$810K |
|
10
Kaiser Aluminum
KALU
$2.56B
| $7.63M | 2.25% |
38,985
-4,476
| -10% | -$761K |
|
11
Lumentum
LITE
$84.2B
| $7.59M | 2.24% |
8,841
-147
| -2% | -$131K |
|
12
Zeta Global
ZETA
$7.64B
| $7.5M | 2.21% |
381,000
-29,257
| -7% | -$543K |
|
|
13
Lantheus
LNTH
$6.56B
| $7.26M | 2.14% |
65,439
+38,015
| +139% | +$3.54M |
|
|
14
Axsome Therapeutics
AXSM
$11.8B
| $7.17M | 2.12% |
29,307
+10,713
| +58% | +$2.32M |
|
15
Meritage Homes
MTH
$4.14B
| $7.06M | 2.08% |
84,158
-6,932
| -8% | -$473K |
|
16
Third Coast Bancshares
TCBX
$748M
| $7.04M | 2.08% |
174,205
+41,443
| +31% | +$1.62M |
|
17
Jefferies Financial Group
JEF
$12.1B
| $6.83M | 2.02% |
136,701
+28,928
| +27% | +$1.49M |
|
18
Astrana Health
ASTH
$1.88B
| $6.77M | 2% |
145,946
-7,754
| -5% | -$279K |
|
19
IMAX
IMAX
$2.86B
| $6.06M | 1.79% |
152,146
-9,961
| -6% | -$382K |
|
20
Magnite
MGNI
$3.43B
| $6.03M | 1.78% |
317,750
-22,792
| -7% | -$327K |
|
21
Ichor Holdings
ICHR
$2.16B
| $5.24M | 1.55% |
46,655
-15,977
| -26% | -$1.15M |
|
|
SF
22
Stifel
SF
$12B
| $5.2M | 1.54% |
74,579
-6,340
| -8% | -$473K |
|
23
Kura Oncology
KURA
$1.02B
| $5.12M | 1.51% |
467,153
-18,970
| -4% | -$179K |
|
24
HealthEquity
HQY
$7.92B
| $4.65M | 1.37% |
51,501
-4,271
| -8% | -$362K |
|
25
Granite Construction
GVA
$5.22B
| $4.53M | 1.34% |
28,645
-3,627
| -11% | -$493K |
|
Similar funds
ECAM
FC
EWA
NIWA
HFS
BAM
JWM
RSA
1492 Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, 1492 Capital Management held 143 positions worth $339M, up 29% from $263M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
1492 Capital Management withdrew a net $23.3M in Q2 2026, closing 10 positions and reducing 79 holdings. Its most notable exit was Permian Resources, an estimated $3.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 1492 Capital Management opened a new position in SGHC Ltd worth $2.87M.
- 1492 Capital Management's largest Q2 2026 buy was SGHC Ltd: 211,740 shares worth $2.87M.
- 1492 Capital Management added most to Lantheus in Q2 2026, an estimated $3.54M increase.
- 1492 Capital Management's biggest Q2 2026 reduction was MaxLinear, cutting an estimated $12.8M.
- 1492 Capital Management fully exited Permian Resources in Q2 2026, selling an estimated $3.7M.
- 1492 Capital Management's ten largest holdings make up 32% of its $339M portfolio in Q2 2026.
- 1492 Capital Management opened 13 new positions and closed 10 in Q2 2026.
- 1492 Capital Management's portfolio value rose 29% quarter-over-quarter to $339M.
Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.